Back
Akebia Therapeutics Vs. iBio Industry Stock Comparison
Buy
66
AKBA
Akebia Therapeutics
Last Price:
2.05
Seasonality Move:
46.76%
Sell
40
IBIO
iBio
Last Price:
2.50
Seasonality Move:
-5.06%
Buy
66
Akebia Therapeutics (AKBA)
is a Buy
Is Akebia Therapeutics a Buy, Sell or Hold?
- The current Akebia Therapeutics [AKBA] share price is $1.93. The Score for AKBA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- AKBA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
iBio (IBIO)
is a Sell
Is iBio a Buy, Sell or Hold?
- The current iBio [IBIO] share price is $2.56. The Score for IBIO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- IBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKBA Stock Price Chart
What is Akebia Therapeutics's stock price today?
-
The Akebia Therapeutics share price today is $1.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKBA is experiencing slight buying pressure.
IBIO Stock Price Chart
AKBA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 63.93 | Buy |
| Chaikin Money Flow: | 283199 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.66 - 1.92) | Buy |
| Bollinger Bands (100): | (1.23 - 1.69) | Buy |
IBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 53.14 | Buy |
| Chaikin Money Flow: | -42530 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.34 - 2.78) | Buy |
| Bollinger Bands (100): | (1.85 - 2.57) | Buy |
AKBA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.84 | Buy |
| 20-day SMA: | 1.84 | Buy |
| 50-day SMA: | 1.56 | Buy |
| 200-day SMA: | 1.41 | Buy |
| 8-day EMA: | 1.86 | Buy |
| 20-day EMA: | 1.8 | Buy |
| 50-day EMA: | 1.64 | Buy |
| 200-day EMA: | 1.41 | Buy |
IBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.34 | Buy |
| 20-day SMA: | 2.5 | Buy |
| 50-day SMA: | 2.44 | Buy |
| 200-day SMA: | 2.04 | Buy |
| 8-day EMA: | 2.44 | Buy |
| 20-day EMA: | 2.47 | Buy |
| 50-day EMA: | 2.42 | Buy |
| 200-day EMA: | 3.87 | Sell |
Akebia Therapeutics Earnings Growth & AKBA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.07 per share.
iBio Earnings Growth & IBIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $103.99 per share, and an increase next year of $5.67 per share.
Akebia Therapeutics Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
iBio Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||